{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:03:52Z","timestamp":1771430632929,"version":"3.50.1"},"reference-count":62,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"unspecified","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["U01CK000490"],"award-info":[{"award-number":["U01CK000490"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["U01CK000633"],"award-info":[{"award-number":["U01CK000633"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","award":["James and Audrey Foster MGH Research Scholar Award"],"award-info":[{"award-number":["James and Audrey Foster MGH Research Scholar Award"]}],"id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,1,21]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To examine outcomes from respiratory pathogens containment strategies focused on international travellers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>\n                      We developed a compartmental model generalisable to respiratory infectious diseases, in which international travellers interact with each other and airline\/airport workers during transit. We used SARS-CoV-2 Omicron surge data (basic reproduction number (R\n                      <jats:sub>0<\/jats:sub>\n                      ): 9.5) as a case example and performed sensitivity and scenario analyses, including varying the R\n                      <jats:sub>0<\/jats:sub>\n                      for different respiratory pathogens.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings<\/jats:title>\n                    <jats:p>A US high-volume airport.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Simulated international travellers and airline\/airport workers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>\n                      Projection of new and imported SARS-CoV-2 infections without intervention (\n                      <jats:italic>No Intervention<\/jats:italic>\n                      ); pre-travel screening for travellers who intend to travel (intended travellers) with PCR (\n                      <jats:italic>Pre-travel PCR<\/jats:italic>\n                      ); or antigen testing (\n                      <jats:italic>Pre-travel Ag<\/jats:italic>\n                      ); mask-wearing guidance for travellers and workers (\n                      <jats:italic>Mask-wearing<\/jats:italic>\n                      ); and a\n                      <jats:italic>Combined<\/jats:italic>\n                      strategy (\n                      <jats:italic>Pre-travel PCR &amp; Mask-wearing<\/jats:italic>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measures<\/jats:title>\n                    <jats:p>The number of new and imported respiratory disease infections over the 90-day simulation period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Over the 90-day simulation, the number of infected travellers entering the USA would be: 1\u2009155\u2009580 (27.2% of 4.2\u2009million (M) intended travellers) with\n                      <jats:italic>No Intervention<\/jats:italic>\n                      ; 709 560\/4.2M (16.7%) with\n                      <jats:italic>Pre-travel PCR<\/jats:italic>\n                      ; 862 330\/4.2M (20.3%) with\n                      <jats:italic>Pre-travel Ag<\/jats:italic>\n                      ; 1033 820\/4.2M (24.4%) with\n                      <jats:italic>Mask-wearing<\/jats:italic>\n                      ; and 650 480\/4.2M (15.3%) with\n                      <jats:italic>Combined<\/jats:italic>\n                      . The number of new infections among airline\/airport workers would be: 25\u2009670 (73.3% of 35\u2009000 workers) with\n                      <jats:italic>No Intervention<\/jats:italic>\n                      ; 25\u2009260 (72.2%) in\n                      <jats:italic>Pre-travel PCR<\/jats:italic>\n                      ; 25\u2009590 (73.1%) in\n                      <jats:italic>Pre-travel Ag<\/jats:italic>\n                      ; 24\u2009630 (70.4%) in\n                      <jats:italic>Mask-wearing<\/jats:italic>\n                      ; and 18\u2009770 (53.6%) in\n                      <jats:italic>Combined<\/jats:italic>\n                      . In scenario analyses, the most impactful parameters were R\n                      <jats:sub>0<\/jats:sub>\n                      of the respiratory pathogen and population immunity level.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      A\n                      <jats:italic>Combined<\/jats:italic>\n                      strategy of pre-travel PCR testing and mask-wearing would most effectively reduce respiratory infection among international travellers and airline\/airport workers, but would still allow a substantial number of infections to enter the USA, especially when the pathogen is highly transmissible.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-105013","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T15:10:24Z","timestamp":1771427424000},"page":"e105013","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of containment strategies for respiratory diseases on infections imported via international travel to the USA: a modelling study"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7542-1801","authenticated-orcid":false,"given":"Satoshi","family":"Koiso","sequence":"first","affiliation":[{"name":"Medical Practice Evaluation Center, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Lee","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Institute for Technology Assessment, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea L","family":"Ciaranello","sequence":"additional","affiliation":[{"name":"Medical Practice Evaluation Center, Boston, Massachusetts, USA"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"},{"name":"Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth A","family":"Freedberg","sequence":"additional","affiliation":[{"name":"Medical Practice Evaluation Center, Boston, Massachusetts, USA"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"},{"name":"Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA"},{"name":"Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA"},{"name":"Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward T","family":"Ryan","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts, USA"},{"name":"Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA"},{"name":"Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA"},{"name":"Traveler's Advice and Immunization Center, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6769-2732","authenticated-orcid":false,"given":"Mohammad S","family":"Jalali","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Institute for Technology Assessment, Boston, Massachusetts, USA"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina C","family":"LaRocque","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts, USA"},{"name":"Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA"},{"name":"Traveler's Advice and Immunization Center, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8721-106X","authenticated-orcid":false,"given":"Emily P","family":"Hyle","sequence":"additional","affiliation":[{"name":"Medical Practice Evaluation Center, Boston, Massachusetts, USA"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"},{"name":"Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA"},{"name":"Traveler's Advice and Immunization Center, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"2026021807100978000_16.2.e105013.1","doi-asserted-by":"publisher","DOI":"10.1007\/s13337-020-00628-5"},{"key":"2026021807100978000_16.2.e105013.2","doi-asserted-by":"crossref","unstructured":"Huremovi\u0107 D . Brief history of pandemics (pandemics throughout history). In: Huremovi\u0107 D , ed. Psychiatry of Pandemics: A Mental Health Response to Infection Outbreak. Cham: Springer International Publishing, 2019: 7\u201335.","DOI":"10.1007\/978-3-030-15346-5_2"},{"key":"2026021807100978000_16.2.e105013.3","doi-asserted-by":"publisher","DOI":"10.1086\/511439"},{"key":"2026021807100978000_16.2.e105013.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2004.00696.x"},{"key":"2026021807100978000_16.2.e105013.5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(05)71089-8","article-title":"Transmission of infectious diseases during commercial air travel","volume":"365","author":"Mangili","year":"2005","journal-title":"The Lancet"},{"key":"2026021807100978000_16.2.e105013.6","doi-asserted-by":"publisher","DOI":"10.1186\/s12992-021-00749-6"},{"key":"2026021807100978000_16.2.e105013.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101915"},{"key":"2026021807100978000_16.2.e105013.8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/epirev\/mxab006","article-title":"Evolution and Reproducibility of Simulation Modeling in Epidemiology and Health Policy Over Half a Century","volume":"43","author":"Jalali","year":"2021","journal-title":"Epidemiol Rev"},{"key":"2026021807100978000_16.2.e105013.9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jnlssr.2021.06.001","article-title":"The collaboration between infectious disease modeling and public health decision-making based on the COVID-19","volume":"2","author":"Niu","year":"2021","journal-title":"Journal of Safety Science and Resilience"},{"key":"2026021807100978000_16.2.e105013.10","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/S2589-7500(20)30268-5","article-title":"Development and dissemination of infectious disease dynamic transmission models during the COVID-19 pandemic: what can we learn from other pathogens and how can we move forward?","volume":"3","author":"Becker","year":"2021","journal-title":"Lancet Digit Health"},{"key":"2026021807100978000_16.2.e105013.11","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1038\/s41564-023-01504-w","article-title":"SARS-CoV-2 evolution in the Omicron era","volume":"8","author":"Roemer","year":"2023","journal-title":"Nat Microbiol"},{"key":"2026021807100978000_16.2.e105013.12","unstructured":"World Health Organization . WHO director-general\u2019s opening remarks at the media briefing. 2023. Available: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing---5-may-2023"},{"key":"2026021807100978000_16.2.e105013.13","doi-asserted-by":"crossref","unstructured":"Zhu S , Harriman K , Liu C , et al . Human cases of highly pathogenic avian influenza a(H5N1)\u2014California, September\u2013December 2024. MMWR Morb Mortal Wkly Rep 2025. doi:10.15585\/mmwr.mm7408a1","DOI":"10.15585\/mmwr.mm7408a1"},{"key":"2026021807100978000_16.2.e105013.14","unstructured":"World Health Organization . Tracking SARS-CoV-2 variants. Available: https:\/\/www.who.int\/activities\/tracking-SARS-CoV-2-variants [Accessed 25 Mar 2025]."},{"key":"2026021807100978000_16.2.e105013.15","doi-asserted-by":"crossref","unstructured":"Koiso S , Gulbas E , Dike L , et al . Modeling approaches to inform travel-related policies for COVID-19 containment: a scoping review and future directions. Travel Med Infect Dis 2024. doi:10.1016\/j.tmaid.2024.102730","DOI":"10.1016\/j.tmaid.2024.102730"},{"key":"2026021807100978000_16.2.e105013.16","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1098\/rspa.1927.0118","article-title":"A contribution to the mathematical theory of epidemics","volume":"115","author":"Kermack","year":"1927","journal-title":"Proceedings of the Royal Society of London Series A, Containing Papers of a Mathematical and Physical Character"},{"key":"2026021807100978000_16.2.e105013.17","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00768-4"},{"key":"2026021807100978000_16.2.e105013.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02138-x"},{"key":"2026021807100978000_16.2.e105013.19","unstructured":"John F K , Weissman Center for International Business, Baruch College\/CUNY 2021 . International airport (JFK) - statistics 2003-2017. nycdata. Available: https:\/\/www.baruch.cuny.edu\/nycdata\/travel\/jfk-stats.htm [Accessed 25 Mar 2025]."},{"key":"2026021807100978000_16.2.e105013.20","unstructured":"U.S. Department of Transportation, Research and Innovative Technology Administration, Bureau of Transportation Statistics . T-100 market data. 2023. Available: https:\/\/www.transtats.bts.gov\/data_elements.aspx [Accessed 10 Apr 2025]."},{"key":"2026021807100978000_16.2.e105013.21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.15585\/mmwr.mm7222a3","article-title":"Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status \u2014 United States, April 2021\u2013September 2022","volume":"72","author":"Jones","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026021807100978000_16.2.e105013.22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15585\/mmwr.mm7208a2","article-title":"Effect of Predeparture Testing on Postarrival SARS-CoV-2-Positive Test Results Among International Travelers - CDC Traveler-Based Genomic Surveillance Program, Four U.S. Airports, March-September 2022","volume":"72","author":"Bart","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026021807100978000_16.2.e105013.23","doi-asserted-by":"crossref","DOI":"10.2196\/38196","article-title":"The Importance of Incorporating At-Home Testing Into SARS-CoV-2 Point Prevalence Estimates: Findings From a US National Cohort, February 2022","volume":"8","author":"Qasmieh","year":"2022","journal-title":"JMIR Public Health Surveill"},{"key":"2026021807100978000_16.2.e105013.24","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10071049","article-title":"Percentage of Asymptomatic Infections among SARS-CoV-2 Omicron Variant-Positive Individuals: A Systematic Review and Meta-Analysis","volume":"10","author":"Shang","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"2026021807100978000_16.2.e105013.25","doi-asserted-by":"crossref","first-page":"102361","DOI":"10.1016\/j.tmaid.2022.102361","article-title":"Effect of Omicron on the prevalence of COVID-19 in international travelers at the Mexico city international airport. December 16th, 2021 to January 31st, 2022","volume":"49","author":"Olaiz-Fern\u00e1ndez","year":"2022","journal-title":"Travel Med Infect Dis"},{"key":"2026021807100978000_16.2.e105013.26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.27241","article-title":"Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity","volume":"5","author":"Joung","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026021807100978000_16.2.e105013.27","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taac037","article-title":"The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta","volume":"29","author":"Liu","year":"2022","journal-title":"J Travel Med"},{"key":"2026021807100978000_16.2.e105013.28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijid.2022.10.033","article-title":"Transmission dynamics of SARS-CoV-2 Omicron variant infections in Hangzhou","volume":"126","author":"Xin","year":"2022","journal-title":"Int J Infect Dis"},{"key":"2026021807100978000_16.2.e105013.29","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1016\/S2666-5247(23)00005-8","article-title":"SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor study","volume":"4","author":"Galmiche","year":"2023","journal-title":"Lancet Microbe"},{"key":"2026021807100978000_16.2.e105013.30","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S0140-6736(22)00327-0","article-title":"Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study","volume":"399","author":"Menni","year":"2022","journal-title":"The Lancet"},{"key":"2026021807100978000_16.2.e105013.31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/jama.2021.24868","article-title":"Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves","volume":"327","author":"Maslo","year":"2022","journal-title":"JAMA"},{"key":"2026021807100978000_16.2.e105013.32","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-022-07971-6","article-title":"Real-time analysis of hospital length of stay in a mixed SARS-CoV-2 Omicron and Delta epidemic in New South Wales, Australia","volume":"23","author":"Tobin","year":"2023","journal-title":"BMC Infect Dis"},{"key":"2026021807100978000_16.2.e105013.33","doi-asserted-by":"publisher","DOI":"10.3390\/vl4122736"},{"key":"2026021807100978000_16.2.e105013.34","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13062","article-title":"Comparative hospitalization risk for SARS\u2010CoV\u20102 Omicron and Delta variant infections, by variant predominance periods and patient\u2010level sequencing results, New York City, August 2021\u2013January 2022","volume":"17","author":"Greene","year":"2023","journal-title":"Influenza Resp Viruses"},{"key":"2026021807100978000_16.2.e105013.35","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.15585\/mmwr.mm7137a4","article-title":"Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods \u2014 United States, April 2020\u2013June 2022","volume":"71","author":"Adjei","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026021807100978000_16.2.e105013.36","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7106e2"},{"key":"2026021807100978000_16.2.e105013.37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.15585\/mmwr.mm7104e4","article-title":"Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods \u2014 United States, December 2020\u2013January 2022","volume":"71","author":"Iuliano","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026021807100978000_16.2.e105013.38","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069761","article-title":"Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study","volume":"376","author":"Lauring","year":"2022","journal-title":"BMJ"},{"key":"2026021807100978000_16.2.e105013.39","doi-asserted-by":"crossref","DOI":"10.1186\/s40001-023-01047-0","article-title":"The reproduction rate of severe acute respiratory syndrome coronavirus 2 different variants recently circulated in human: a narrative review","volume":"28","author":"Karimizadeh","year":"2023","journal-title":"Eur J Med Res"},{"key":"2026021807100978000_16.2.e105013.40","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1093\/cid\/ciad032","article-title":"The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing (January 2023)","volume":"78","author":"Hayden","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026021807100978000_16.2.e105013.41","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00129-9"},{"key":"2026021807100978000_16.2.e105013.42","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm695152a3"},{"key":"2026021807100978000_16.2.e105013.43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/infdis\/jiac317","article-title":"Sensitivity of Reverse Transcription Polymerase Chain Reaction Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Through Time","volume":"227","author":"Binny","year":"2022","journal-title":"J Infect Dis"},{"key":"2026021807100978000_16.2.e105013.44","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cmi.2020.10.003","article-title":"Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting","volume":"27","author":"Skittrall","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2026021807100978000_16.2.e105013.45","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/aje\/kwab093","article-title":"Diagnostic Accuracy Estimates for COVID-19 Real-Time Polymerase Chain Reaction and Lateral Flow Immunoassay Tests With Bayesian Latent-Class Models","volume":"190","author":"Kostoulas","year":"2021","journal-title":"Am J Epidemiol"},{"key":"2026021807100978000_16.2.e105013.46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.15585\/mmwr.mm7316a2","article-title":"SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance \u2014 Respiratory Virus Transmission Network, November 2022\u2013May 2023","volume":"73","author":"Smith-Jeffcoat","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026021807100978000_16.2.e105013.47","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7106e1"},{"key":"2026021807100978000_16.2.e105013.48","doi-asserted-by":"publisher","DOI":"10.1126\/science.abg6296"},{"key":"2026021807100978000_16.2.e105013.49","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00637-20"},{"key":"2026021807100978000_16.2.e105013.50","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2022.100337","article-title":"Association between two mass-gathering outdoor events and incidence of SARS-CoV-2 infections during the fifth wave of COVID-19 in north-east Spain: A population-based control-matched analysis","volume":"15","author":"Su\u00f1er","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"2026021807100978000_16.2.e105013.51","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7006e1"},{"key":"2026021807100978000_16.2.e105013.52","unstructured":"U.S. Department of Homeland Security . TSA to implement executive order regarding face masks at airport security checkpoints and throughout the transportation network. 2021. Available: https:\/\/www.tsa.gov\/news\/press\/releases\/2021\/01\/31\/tsa-implement-executive-order-regarding-face-masks-airport-security [Accessed 25 Mar 2025]."},{"key":"2026021807100978000_16.2.e105013.53","unstructured":"U.S. Department of State . Negative COVID-19 test required for travel to the united states beginning January 26. U S Dep State; 2021. Available: https:\/\/2021-2025.state.gov\/negative-covid-19-test-required-for-travel-to-the-united-states-beginning-january-26\/ [Accessed 25 Mar 2025]."},{"key":"2026021807100978000_16.2.e105013.54","unstructured":"Centers for Disease Control and Prevention, U.S. Department of Health and Human Services . Rescinding requirement for negative pre-departure COVID-19 test result or documentation of recovery from COVID-19 for all airline or other aircraft passengers arriving into the united states from any foreign country. 2022."},{"key":"2026021807100978000_16.2.e105013.55","unstructured":"U.S. Department of Homeland Security . TSA extends face mask requirement through May 3, 2022. 2022. Available: https:\/\/www.tsa.gov\/news\/press\/statements\/2022\/04\/13\/tsa-extends-face-mask-requirement-through-may-3-2022 [Accessed 25 Mar 2025]."},{"key":"2026021807100978000_16.2.e105013.56","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg3691","article-title":"Safe traveling in public transport amid COVID-19","volume":"7","author":"Ku","year":"2021","journal-title":"Sci Adv"},{"key":"2026021807100978000_16.2.e105013.57","unstructured":"Centers for Disease Control and Prevention . Masks and respiratory viruses prevention. respir. illnesses. 2024. Available: https:\/\/www.cdc.gov\/respiratory-viruses\/prevention\/masks.html [Accessed 25 Mar 2025]."},{"key":"2026021807100978000_16.2.e105013.58","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph21060654","article-title":"The Risk of Aircraft-Acquired SARS-CoV-2 Transmission during Commercial Flights: A Systematic Review","volume":"21","author":"Zhao","year":"2024","journal-title":"Int J Environ Res Public Health"},{"key":"2026021807100978000_16.2.e105013.59","unstructured":"U.S. Department of Labor . Occupational safety and health act of 1970. 1970."},{"key":"2026021807100978000_16.2.e105013.60","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7208a3"},{"key":"2026021807100978000_16.2.e105013.61","unstructured":"Centers for Disease Control and Prevention . Traveler-based genomic surveillance for early detection of new sars-CoV-2 variants. Travel Health; 2024. Available: https:\/\/wwwnc.cdc.gov\/travel\/page\/travel-genomic-surveillance [Accessed 25 Mar 2025]."},{"key":"2026021807100978000_16.2.e105013.62","unstructured":"The White House . Fact sheet: biden administration releases additional detail for implementing a safer, more stringent international air travel system. White House; 2021. Available: https:\/\/www.whitehouse.gov\/briefing-room\/statements-releases\/2021\/10\/25\/fact-sheet-biden-administration-releases-additional-detail-for-implementing-a-safer-more-stringent-international-air-travel-system\/ [Accessed 25 Mar 2025]."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-105013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T15:10:38Z","timestamp":1771427438000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-105013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":62,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,18]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/bmjopen-2025-105013"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-105013","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}